Effects of morpholino-, pyrrolidino-, piperizino-, and cyclo-octyl-derivatives of beta-alanine on brain amines and amino acids.
D000409:Alanine / Q000494:pharmacology*; D000588:Amines / Q000032:analysis*; D000596:Amino Acids / Q000032:analysis*; D000613:Aminobutyrates / Q000032:analysis; D000818:Animals; D001792:Blood Platelets / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D003516:Cycloparaffins / Q000494:pharmacology*; D004298:Dopamine / Q000032:analysis; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000032:analysis; D008238:Lysergic Acid Diethylamide; D008297:Male; D009025:Morpholines / Q000494:pharmacology*; D009638:Norepinephrine / Q000032:analysis; D010879:Piperazines / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000032:analysis / Q000378:metabolism; D014364:Tryptophan / Q000032:analysis / Q000097:blood; D014443:Tyrosine / Q000032:analysis / Q000097:blood
D000588:Amines; D000596:Amino Acids; D000613:Aminobutyrates; D003516:Cycloparaffins; D009025:Morpholines; D010879:Piperazines; D011759:Pyrrolidines; D012701:Serotonin; D014443:Tyrosine; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan; D008238:Lysergic Acid Diethylamide; D000409:Alanine; D004298:Dopamine; D009638:Norepinephrine